In this video Professor Zemel discusses OS200 the regulated therapy that NuSirt is currently in human trials with for obesity, NAFLD and pre-diabetes. The therapy includes leucine, metformin and sildenafil.
Dr Michael Zemel is Professor Emeritus at the University of Tennessee and the founder and chief scientific officer at NuSirt, a company developing solutions to treat chronic diseases of aging and over nutrition. In his 40 years of academic research he has authored more than 200 peer reviewed publications.
🌐NuSirt Biopharma web site https://nusirt.com/
Some links are affiliate links so we will earn a commission when they are used to purchase products.
NOVOS Core & NOVOS Boost https://novoslabs.com/?ref=3957 $5 off any purchase if users use code MODERNnow5
10% off DoNotAge all products with discount code MODERNHEALTHSPAN https://donotage.org/products/
10% Discount on Renue By Science products with code MHS https://renuebyscience.com/
Use SUBMHS for subscriptions
ProHealth 10% of all products Code MODERN: https://www.prohealth.com/
